Search

Your search keyword '"Ertekin-Taner, Nilufer"' showing total 610 results

Search Constraints

Start Over You searched for: Author "Ertekin-Taner, Nilufer" Remove constraint Author: "Ertekin-Taner, Nilufer"
610 results on '"Ertekin-Taner, Nilufer"'

Search Results

1. Whole genome‐wide sequence analysis of long‐lived families (Long‐Life Family Study) identifies MTUS2 gene associated with late‐onset Alzheimer's disease

2. LATE-NC risk alleles (in TMEM106B, GRN, and ABCC9 genes) among persons with African ancestry.

3. Role of GBA variants in Lewy body disease neuropathology

6. The UFMylation pathway is impaired in Alzheimer's disease

7. Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD

8. Mitochondrial genomic variation in dementia with Lewy bodies: association with disease risk and neuropathological measures

10. Transethnic genome‐wide scan identifies novel Alzheimer's disease loci

11. ABCA7 frameshift deletion associated with Alzheimer disease in African Americans

12. Assessment of the genetic variance of late-onset Alzheimer's disease

13. Single cell profiling of Microglia from PLCG2 and ABI3 Missense Variant Carriers in Alzheimer’s disease

14. Investigating phenotypic modifiers of Alzheimer’s disease utilizing cellular and transcriptomic signatures of PSEN1 mutation carriers

16. Distinct amyloid‐β deposits inversely correlate with glial activation and tangles in Alzheimer’s disease subtypes

17. Plasma biomarkers of Alzheimer’s disease in a biracial, community‐based sample

18. Gliovascular molecular alterations in Alzheimer’s disease: a cross‐tissue, cross‐species study

20. Blood co‐expression network analysis identifies molecular pathways involved in cognitive resilience

22. Network‐based pipeline guides knowledge‐driven prioritization and validation of therapeutic target discovery for Alzheimer’s disease

23. Identification of genes and blood co‐expression networks associated with cerebrovascular neuroimaging phenotypes

25. Targeted plasma eQTL and pQTL to identify potential novel biomarkers for Alzheimer’s Disease in African Americans

26. DNA methylation clustered by predicted chromatin state reveals distinct association patterns with neuropathologic and biochemical measures in the AD brain

27. Digital pathology analysis reveals TDP‐43 pathology as a strong predictor of glial activation in Alzheimer’s disease

28. Association of Long Runs of Homozygosity With Alzheimer Disease Among African American Individuals

29. A molecular pathology, neurobiology, biochemical, genetic and neuroimaging study of progressive apraxia of speech

30. Rarity of the Alzheimer Disease-Protective APP A673T Variant in the United States

31. Effects of Multiple Genetic Loci on Age at Onset in Late-Onset Alzheimer Disease

32. Alzheimer's disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci

33. Retrospective Evaluation of Neuropathologic Proxies of the Minimal Atrophy Subtype Compared With Corticolimbic Alzheimer Disease Subtypes

34. CWH43Variants Are Associated With Disease Risk and Clinical Phenotypic Measures in Patients With Normal Pressure Hydrocephalus

35. Alzheimer's disease and progressive supranuclear palsy share similar transcriptomic changes in distinct brain regions

37. Systems biology approach to late-onset Alzheimer's disease genome-wide association study identifies novel candidate genes validated using brain expression data and Caenorhabditis elegans experiments

38. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease

39. Primary progressive apraxia of speech: Clinico-pathological associations of left-right hemispheric dominance (S8.008)

40. Transethnic genome-wide scan identifies novel Alzheimer's disease loci

41. CWH43 Variants Are Associated With Disease Risk and Clinical Phenotypic Measures in Patients With Normal Pressure Hydrocephalus.

42. The influence of β-amyloid on [18F]AV-1451 in semantic variant of primary progressive aphasia

44. Clinicopathological associations of hemispheric dominance in primary progressive apraxia of speech

45. Abstract WMP76: Carotid Revascularization Slows Hemispheric White Matter Disease Progression

46. Genetic and lifestyle risk factors for MRI-defined brain infarcts in a population-based setting

47. Single Cell Approaches Reveal Perturbed Brain Vascular Molecules in Alzheimer’s Disease

48. Brain region‐specific metabolic signatures of Alzheimer’s disease

49. Integrative single‐nucleus RNAseq analysis identifies cell‐type‐specific expression perturbations in progressive supranuclear palsy

50. Digital Pathology Investigation of SERPINA5‐Tau Protein Interaction in Alzheimer’s Disease and Primary Tauopathies

Catalog

Books, media, physical & digital resources